# Prevention of HIV in "Île-de-France"

> **NCT03113123** · NA · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 3257 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** PrEP with Truvada®

## Key facts

- **NCT ID:** NCT03113123
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-03
- **Primary completion:** 2024-05-02
- **Final completion:** 2024-10
- **Target enrollment:** 3257 (ESTIMATED)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113123, "Prevention of HIV in "Île-de-France"". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03113123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*